Global Vaccine Patent Disputes Expose Inequitable Distribution of COVID-19 Technologies
Original framing: “BioNTech sues Moderna for patent infringement over COVID shots - Reuters” — Reuters (via Google News)
The original framing omits the historical parallels of vaccine development and the role of colonialism in shaping global health inequities, as well as the perspectives of low- and middle-income countries.
Low structural omission detected in mainstream coverage.
This narrative was produced by Reuters, a Western news agency, for a global audience, serving the power structures of pharmaceutical corporations and Western governments while obscuring the perspectives of low- and middle-income countries.
The history of vaccine development is marked by colonialism and exploitation, shaping global health inequities and informing the current patent disputes.
The patent dispute between BioNTech and Moderna exposes the systemic issues surrounding vaccine development and distribution, highlighting the need for a more inclusive and equitable approach to global health.